The "14th Five-Year Plan" for the development of traditional Chinese medicine is promulgated, which is beneficial to the six categories of traditional Chinese medicinal materials!

On March 29, 2022, the General Office of the State Council issued the "14th Five-Year Plan for the Development of Traditional Chinese Medicine" (hereinafter referred to as the "Plan") to make a comprehensive deployment of traditional Chinese medicine during the "14th Five-Year Plan" period
.
This is the first five-year plan for traditional Chinese medicine issued in the name of the General Office of the State Council in accordance with the country's "Fourteenth Five-Year Plan for National Economic and Social Development and Outline of Vision 2035".
Quality development clarifies measures and provides guarantees
.
01
.
From the perspective of the Chinese herbal medicine industry, how should we understand the "Planning"? First of all, the Chinese herbal medicine industry cannot be absent in the construction of a large health system.
Figure 1: The state's positioning of the Chinese medicine industry (source: "Outline of the Strategic Plan for the Development of Chinese Medicine (2016-2030)") The material basis of the big health industry, the Chinese herbal medicine industry is indispensable in the country's five strategic positioning for the Chinese medicine industry
.
Chinese medicinal materials are not only unique health resources, but also important ecological resources, cultural resources, scientific and technological resources and economic resources
.
From a microscopic level, the coordinated development of "integration of medicine" is also the core value and objective development law of the Chinese medicine industry.
The development of the Chinese herbal medicine industry is a water without a source and a tree without roots when it is separated from the theory and clinical practice of traditional Chinese medicine.
Traditional Chinese medicine has lost its actual weapons and core means
.
Therefore, the "Plan" puts the coordinated development of the Chinese medicine industry in an important position, focusing on promoting the high-quality development of the Chinese medicine industry, and proposes to strengthen the protection and utilization of traditional Chinese medicine resources, strengthen the production management of authentic medicinal materials, improve the development level of the traditional Chinese medicine industry, and strengthen the safety supervision of traditional Chinese medicine, etc.
4 Specific measures in each aspect, and guarantees from laws and regulations, service systems, talent protection and other aspects
.
Secondly, the "Plan" is the specific implementation of the national strategy for the revitalization of traditional Chinese medicine.
Figure 2: In recent years, the state has released key policies related to traditional Chinese medicine (organized by the sky and the clouds) Covering the whole industry chain of traditional Chinese medicine from the perspective of overall situation, supporting policies and laws and regulations
.
The "Plan" is a specific measure to implement the programmatic documents such as the "National Law on Traditional Chinese Medicine", the "Outline of the Strategic Plan for the Development of Traditional Chinese Medicine (2016-2030)" and the "Opinions of the Central Committee of the Communist Party of China and the State Council on Promoting the Innovative Development of Traditional Chinese Medicine" , pointing out the direction and marking the key points for the development of the Chinese medicine industry in the next five years, which should attract the attention of the whole industry
.
Finally, there are shortcomings in industrial development, and high-quality development is the key Figure 3: The quality improvement project of traditional Chinese medicine (from the "14th Five-Year Plan for the Development of Traditional Chinese Medicine") We also see that in the "planning background", it is emphasized that " The quality of Chinese herbal medicines varies from good to bad" is a key issue in the development of the industry
.
Then in the "main tasks", it is emphasized that the quality of traditional Chinese medicine should be achieved through four major starting points: "strengthening the protection and utilization of traditional Chinese medicine resources", "strengthening the production management of authentic medicinal materials", "improving the development level of the traditional Chinese medicine industry" and "strengthening the safety supervision of traditional Chinese medicine".
Lift engineering
.
02.
After the implementation of the "Plan", which varieties of Chinese medicinal materials will be beneficial? First, the wild imitation wild medicinal material species under the forest.
On the one hand, the unsustainability of wild Chinese medicinal material resources has become an important bottleneck for the healthy development of the traditional Chinese medicine industry; serious
.
As shown in Figure 4, Qianghuo, which should have grown in a humid and shady environment, was transplanted to a sunny slope environment, and its quality changed, and its efficacy was significantly lower than that of wild plants
.
Therefore, the "Plan" clearly proposes to "support the artificial breeding of rare and endangered Chinese herbal medicines", "to formulate technical specifications and standards for the harvesting, production area processing, wild tending and imitation wild cultivation of Chinese herbal medicines", which will certainly promote the use of imitation wild, three-dimensional The economic development of Chinese herbal medicine under the forest is characterized by planting
.
Second, the origin and varieties of authentic medicinal materials Daodi medicinal materials are advantageous traditional Chinese medicine resources handed down from history, but due to the extensive development path of “focusing on output and ignoring quality” for a long time, the resources of many varieties of authentic medicinal materials in China are unsustainable, Provenance variation even disappeared, such as "Liangwai Licorice", "Shipai Huoxiang" and "Jian Alisma"
.
The "Planning" proposes "to formulate and publish a national catalogue of authentic medicinal materials, and to build a breeding system for improved varieties of Chinese medicinal materials.

.
Strengthen the construction of the breeding bases and production bases of authentic medicinal materials”, “strengthen the protection of geographical indications for authentic medicinal materials, and cultivate a number of well-known brands of authentic medicinal materials”.
To make the authentic medicinal material brand bigger and stronger will definitely benefit the inheritance and development of the authentic medicinal material producing areas and varieties across the country
.
Third, the raw materials of traditional Chinese medicinal materials are traceable and standardized in accordance with the "standardized production of GAP bases", and the whole process of quality traceability has become a general trend.
Relevant norms and supporting policies have also been introduced one after another
.
The "Planning" once again emphasizes "promoting the standardized planting and breeding of Chinese herbal medicines", "researching and promoting the construction of an information traceability system for Chinese herbal medicines and Chinese herbal decoction pieces, and strengthening multi-department collaborative supervision
.
" The bases and which production enterprises are the first to implement them will surely seize this wave of policy dividends and take the lead in the market competition
.
In the past 20 years, the social demand for medicinal and edible varieties has grown significantly, accounting for about 80% of the overall consumption of Chinese medicinal materials; at the same time, it also contributed 80% of the increase in domestic demand for Chinese medicinal materials in the past 15 years, as shown in the figure 5.
From 2008 to 2021, the overall demand for 110 kinds of medicinal and edible Chinese medicinal materials will increase from 1.
1862 million tons to 1.
8955 million tons, with an average annual compound growth rate of 3.
61%, making it the most dazzling sector in the entire Chinese medicinal material field
.
It not only strengthened the "enriching the supply of traditional Chinese medicine health products, focusing on health food, formula food for special medical purposes, functional cosmetics, and daily chemical products, and developing traditional Chinese medicine health products", but also clearly stated that "the traditional Chinese medicine decoction pieces prepared and used by medical institutions, Traditional Chinese medicine preparations are priced independently, and those that meet the conditions will be included in the payment scope of basic medical insurance according to procedures”, etc.
, which will inevitably further promote the innovation of products and channels of a variety of medicinal and edible varieties, expand the incremental market for medicinal and edible varieties, and become the The new economic growth point of the traditional Chinese medicine industry
.
Fifth, the "Plan" also clearly states that infectious diseases such as the new crown epidemic are the biggest threats and challenges facing human health.
Traditional Chinese medicine has and will continue to play a role in its unique advantages
.
In this context, the raw materials of medicinal materials for fighting the epidemic and for public health emergencies and first aid are bound to attract the attention of the whole society and will benefit people around the world
.
For example, Lianhua Qingwen series, Huoxiangzhengqi series, Qingfeibaidu drink, as well as the raw materials for Xuebijing, An Gong Niuhuang and Pien Tze Huang series products for severe and emergency treatment will become key supply guarantees during the "14th Five-Year Plan" period.
Targets, some core raw materials are not excluded from domestic strategic reserves, and rare medicinal materials such as bezoar and musk will further strengthen national control.
Sixth, ethnic minority medicine Chinese medicine itself integrates the essence of 56 ethnic folk medicine, and is a common material and culture of the Chinese nation.
wealth
.
For example, "Yunyao", "Mongolian medicine", "Tibetan medicine", "Taibai seven medicines" and Yao medicine "Five Tigers, Nine Bulls, Eighteen Diamonds, Seventy-two Winds" series, etc.
, are mostly developed from the medicine of ethnic minorities.
Since then, more than 130 ethnic pharmaceutical companies have been born
.
The "Plan" emphasizes "increasing the inheritance and protection of ethnic medicine, continuing to carry out the rescue and sorting of ethnic medicine literature, and promoting theoretical innovation and technological innovation".
The production and development of a series of medicinal materials such as Jintiesuo, Panlongqi, Taoerqi, Black Tiger, and Rock cabbage, as well as the development of the back-end industrial chain
.
Of course, in addition to the above six categories, the production and supply of the core raw materials required for classic prescriptions, the core raw materials required for new traditional Chinese medicines, the raw materials of traditional Chinese medicine granules, and the varieties of proprietary Chinese medicines will also receive focus on the production and supply.
The policy is inclined, and the vast number of origins and production enterprises should carefully study the "Planning" and make arrangements in advance, so that more "gold" can be found in the "rich ore" of the traditional Chinese medicine industry in the next five years
.
(The author is the chief analyst of the big data platform for the pharmaceutical industry in Tiandi Yuntu)